Iguana Healthcare Management as of June 30, 2016
Portfolio Holdings for Iguana Healthcare Management
Iguana Healthcare Management holds 82 positions in its portfolio as reported in the June 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 5.0 | $12M | 125k | 98.63 | |
Zimmer Holdings (ZBH) | 4.9 | $12M | 100k | 120.38 | |
Gilead Sciences (GILD) | 4.6 | $11M | 135k | 83.42 | |
Shire | 4.5 | $11M | 60k | 184.08 | |
Anthem (ELV) | 3.7 | $9.2M | 70k | 131.34 | |
Oncomed Pharmaceuticals | 3.2 | $7.8M | 632k | 12.31 | |
Merck & Co (MRK) | 2.9 | $7.2M | 125k | 57.61 | |
Pfizer (PFE) | 2.9 | $7.0M | 200k | 35.21 | |
Ultragenyx Pharmaceutical (RARE) | 2.8 | $6.8M | 140k | 48.91 | |
Baxter International (BAX) | 2.5 | $6.1M | 135k | 45.22 | |
NuVasive | 2.4 | $6.0M | 100k | 59.72 | |
Alexion Pharmaceuticals | 2.4 | $5.8M | 50k | 116.76 | |
ALEXION PHARMACEUTICALS INC CMN Stock cmn | 2.4 | $5.8M | 50k | 116.76 | |
Biogen Idec (BIIB) | 2.2 | $5.4M | 23k | 241.82 | |
Amgen (AMGN) | 2.2 | $5.3M | 35k | 152.14 | |
Global Blood Therapeutics In | 2.0 | $5.0M | 300k | 16.59 | |
Medicines | 1.9 | $4.7M | 140k | 33.63 | |
Supernus Pharmaceuticals (SUPN) | 1.9 | $4.6M | 225k | 20.37 | |
Dermira | 1.8 | $4.4M | 150k | 29.25 | |
Tenet Healthcare Corporation (THC) | 1.7 | $4.1M | 150k | 27.64 | |
Glaukos (GKOS) | 1.6 | $3.9M | 135k | 29.16 | |
Lilly Eli & Co option | 1.6 | $3.9M | 50k | 78.16 | |
Hca Holdings (HCA) | 1.6 | $3.9M | 50k | 77.02 | |
Mazor Robotics Ltd. equities | 1.5 | $3.6M | 200k | 17.98 | |
Illumina (ILMN) | 1.4 | $3.5M | 25k | 140.40 | |
Cigna Corp | 1.3 | $3.2M | 25k | 128.00 | |
Allscripts Healthcare Solutions (MDRX) | 1.3 | $3.2M | 250k | 12.70 | |
Abbvie | 1.3 | $3.1M | 50k | 61.92 | |
Spark Therapeutics | 1.2 | $3.1M | 60k | 51.13 | |
Exelixis (EXEL) | 1.1 | $2.7M | 350k | 7.81 | |
Aerie Pharmaceuticals | 1.1 | $2.6M | 150k | 17.60 | |
Healthways | 1.1 | $2.6M | 225k | 11.55 | |
Kite Pharma | 1.0 | $2.5M | 50k | 50.00 | |
Boston Scientific Corporation (BSX) | 0.9 | $2.3M | 100k | 23.37 | |
Accelr8 Technology | 0.9 | $2.2M | 150k | 14.39 | |
K2m Group Holdings | 0.9 | $2.2M | 140k | 15.52 | |
Spectranetics Corporation | 0.8 | $2.1M | 110k | 18.71 | |
Epizyme | 0.8 | $2.0M | 200k | 10.24 | |
Medicines Company | 0.8 | $2.0M | 60k | 33.63 | |
Macrogenics (MGNX) | 0.8 | $2.0M | 75k | 26.99 | |
Intersect Ent | 0.8 | $1.9M | 150k | 12.93 | |
BioScrip | 0.8 | $1.9M | 750k | 2.55 | |
Radius Health | 0.8 | $1.8M | 50k | 36.76 | |
Radius Health Inc cmn | 0.8 | $1.8M | 50k | 36.76 | |
UnitedHealth (UNH) | 0.7 | $1.8M | 13k | 141.20 | |
Acceleron Pharma | 0.7 | $1.7M | 50k | 33.98 | |
Adaptimmune Therapeutics (ADAP) | 0.7 | $1.6M | 200k | 8.15 | |
PharMerica Corporation | 0.7 | $1.6M | 65k | 24.66 | |
WELLCARE HEALTH PLANS INC COMMON Stock cmn | 0.7 | $1.6M | 15k | 107.27 | |
Merus N V (MRUS) | 0.7 | $1.6M | 200k | 7.99 | |
Adamas Pharmaceuticals | 0.6 | $1.5M | 100k | 15.14 | |
Sage Therapeutics Inc call | 0.6 | $1.5M | 50k | 30.14 | |
Seres Therapeutics (MCRB) | 0.6 | $1.5M | 50k | 29.06 | |
Cytokinetics (CYTK) | 0.6 | $1.4M | 150k | 9.49 | |
Applied Genetic Technol Corp C | 0.6 | $1.4M | 100k | 14.13 | |
Alnylam Pharmaceuticals (ALNY) | 0.6 | $1.4M | 25k | 55.48 | |
ALNYLAM PHARMACEUTICALS INC. Common Stock cmn | 0.6 | $1.4M | 25k | 55.48 | |
Revance Therapeutics (RVNC) | 0.6 | $1.4M | 100k | 13.60 | |
Tandem Diabetes Care | 0.5 | $1.3M | 175k | 7.54 | |
Alkermes (ALKS) | 0.5 | $1.3M | 30k | 43.23 | |
Minerva Neurosciences | 0.5 | $1.3M | 125k | 10.21 | |
Coherus Biosciences (CHRS) | 0.5 | $1.3M | 75k | 16.89 | |
Walgreen Boots Alliance (WBA) | 0.5 | $1.2M | 15k | 83.27 | |
Clovis Oncology | 0.5 | $1.2M | 90k | 13.72 | |
Mylan Nv | 0.4 | $1.1M | 25k | 43.24 | |
Intra Cellular Therapies (ITCI) | 0.4 | $971k | 25k | 38.84 | |
Flamel Technologies | 0.3 | $806k | 75k | 10.75 | |
Adma Biologics (ADMA) | 0.3 | $744k | 125k | 5.95 | |
Seres Therapeutics Inc put | 0.3 | $726k | 25k | 29.04 | |
Sangamo Biosciences (SGMO) | 0.3 | $724k | 125k | 5.79 | |
Pacific Biosciences of California (PACB) | 0.3 | $704k | 100k | 7.04 | |
Chemocentryx | 0.3 | $674k | 150k | 4.49 | |
Medivation | 0.2 | $603k | 10k | 60.30 | |
Endochoice Hldgs | 0.2 | $613k | 125k | 4.90 | |
Immunomedics | 0.2 | $522k | 225k | 2.32 | |
Clearside Biomedical (CLSD) | 0.2 | $526k | 75k | 7.01 | |
D Fluidigm Corp Del (LAB) | 0.2 | $452k | 50k | 9.04 | |
Exelixis Inc Cmn Stk cmn | 0.2 | $391k | 50k | 7.82 | |
Novavax Inc Cmn Stock cmn | 0.1 | $364k | 50k | 7.28 | |
Rigel Pharmaceuticals | 0.1 | $335k | 150k | 2.23 | |
Scynexis | 0.1 | $271k | 125k | 2.17 | |
Rigel Pharmaceuticals Inc cmn | 0.1 | $112k | 50k | 2.24 |